tiprankstipranks
Trending News
More News >
Prime Medicine downgraded to Neutral from Buy at Citi
PremiumThe FlyPrime Medicine downgraded to Neutral from Buy at Citi
1M ago
Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments
Premium
Ratings
Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments
1M ago
Hold Rating on Prime Medicine, Inc. Amid Strategic Shifts and Financial Reevaluation
Premium
Ratings
Hold Rating on Prime Medicine, Inc. Amid Strategic Shifts and Financial Reevaluation
2M ago
Prime Medicine, Inc.: Hold Rating Amid Strategic Restructuring and Long-term Uncertainty
PremiumRatingsPrime Medicine, Inc.: Hold Rating Amid Strategic Restructuring and Long-term Uncertainty
2M ago
Prime Medicine downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Prime Medicine downgraded to Neutral from Overweight at JPMorgan
2M ago
Prime Medicine price target lowered to $12 from $16 at Chardan
Premium
The Fly
Prime Medicine price target lowered to $12 from $16 at Chardan
2M ago
Prime Medicine announces initial data from Phase 1/2 study of PM359
PremiumThe FlyPrime Medicine announces initial data from Phase 1/2 study of PM359
2M ago
Prime Medicine’s Promising Clinical Data and Favorable Market Conditions Make It a Buy
Premium
Ratings
Prime Medicine’s Promising Clinical Data and Favorable Market Conditions Make It a Buy
2M ago
Prime Medicine, Inc.: Buy Rating Backed by Promising Gene Editing Advancements and Robust Pipeline
Premium
Ratings
Prime Medicine, Inc.: Buy Rating Backed by Promising Gene Editing Advancements and Robust Pipeline
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100